The Pan African Pulmonary Hypertension Cohort Study

Summary

The study will recruit and follow up patients for six months patients newly diagnosed with pulmonary hypertension from twelve centers across four countries; South Africa, Mozambique, Cameroon, Nigeria. The main aim of the study is to describe the aetiology, natural history and management practices of pulmonary hypertension in Africa.

Conditions

• Pulmonary Hypertension

Interventions

OTHER

standard of care

No intervention, this a patient registry and is purely an observational study

Sponsors & Collaborators

• Doula General Hospital, Cameroon

  collaborator UNKNOWN

• Instituto Nacional de Saúde, Mozambique

  collaborator OTHER_GOV

• Mayo Clinic

  collaborator OTHER

• Aminu Kano Teaching Hospital

  collaborator OTHER

• University of Ibadan

  collaborator OTHER

• Eduardo Mondlane University

  collaborator OTHER

• University of Lagos, Nigeria

  collaborator OTHER

• Khayelitsha District hospital, Cape Town, South Africa

  collaborator UNKNOWN

• Baker Heart Research Institute, Melbourne, Australia

  collaborator UNKNOWN

• Pulmonary Vascular Research Institute, UK

  collaborator UNKNOWN

• University of Cape Town

  lead OTHER

Principal Investigators

• Karen Sliwa-Hahnle, PhD · University of Cape Town

Eligibility

Min Age

1 Year

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2012-06-30

Primary Completion

2013-12-31

Completion

2015-06-30

Countries

• South Africa

Study Locations